NSABP Accrual To Resume Soon; Group ponders Elections, Move To Fox Chase
In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial
Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher
ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust
Clinton Seeks Cut In NIH Increase
Advisory Council To Be Named For Alternative Medicine Cuts
James Shannon, 89, Led NIH In 1960’s Period of Growth
Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









